{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:34:22Z","timestamp":1791434062061,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bja.2025.02.038","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:16:22Z","timestamp":1745997382000},"page":"206-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-3847","authenticated-orcid":false,"given":"Douglas J.","family":"Eleveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-5539","authenticated-orcid":false,"given":"Pieter J.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-714X","authenticated-orcid":false,"given":"Johannes P.","family":"Van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-3998","authenticated-orcid":false,"given":"Jeroen V.","family":"Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.R.F.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.02.038_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ALN.0b013e3181ae8460","article-title":"Is anesthesiology going soft? Trends in fragile pharmacology","volume":"111","author":"Egan","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra\u2013short-acting benzodiazepine","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bja.2025.02.038_bib4","unstructured":"Byfavo Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/byfavo (accessed 3 May 2024)."},{"key":"10.1016\/j.bja.2025.02.038_bib5","unstructured":"BYFAVO drug label Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212295s002lbl.pdf (accessed 3 May 2024)."},{"key":"10.1016\/j.bja.2025.02.038_bib6","first-page":"457","article-title":"Remimazolam: another option for induction of general anesthesia?","volume":"75","author":"Lee","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.bja.2025.02.038_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1213\/ANE.0000000000001009","article-title":"Target-controlled infusion: a mature technology","volume":"122","author":"Absalom","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.02.038_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","article-title":"A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice","volume":"36","author":"Masui","year":"2022","journal-title":"J Anesth"},{"key":"10.1016\/j.bja.2025.02.038_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00540-022-03099-8","article-title":"Equilibration rate constant, ke0, to determine effect-site concentration for the Masui remimazolam population pharmacokinetic model in general anesthesia patients","volume":"36","author":"Masui","year":"2022","journal-title":"J Anesth"},{"key":"10.1016\/j.bja.2025.02.038_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics","volume":"132","author":"Sch\u00fcttler","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects","volume":"132","author":"Eisenried","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2020.109899","article-title":"Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects","volume":"66","author":"Zhou","year":"2020","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.bja.2025.02.038_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bja.2022.02.040","article-title":"Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study","volume":"129","author":"Chae","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.02.038_bib14","first-page":"510","article-title":"Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups","volume":"75","author":"Oh","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.bja.2025.02.038_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/00000542-200311000-00013","article-title":"Using front-end kinetics to optimize target-controlled drug infusions","volume":"99","author":"Avram","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cts.12875","article-title":"Population pharmacokinetics of remimazolam in procedural sedation with nonhomogeneously mixed arterial and venous concentrations","volume":"14","author":"Zhou","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.bja.2025.02.038_bib17","first-page":"244","article-title":"Validity and reliability of the observer's: Assessment of alertness\/sedation scale: study with: intravenous midazolam","volume":"10","author":"Chernik","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bja.2025.02.038_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0009-9236(99)70070-6","article-title":"Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics","volume":"65","author":"Hermann","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bja.2025.02.038_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ALN.0000000000002265","article-title":"Combined recirculatory-compartmental population pharmacokinetic modeling of arterial and venous plasma S (+) and R (\u2013) ketamine concentrations","volume":"129","author":"Henthorn","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib20","first-page":"3957","article-title":"Remimazolam: an updated review of a new sedative and anaesthetic","volume":"16","author":"Hu","year":"2022","journal-title":"Drug Des"},{"key":"10.1016\/j.bja.2025.02.038_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/B:JOPA.0000012999.36063.4e","article-title":"Simultaneous vs. sequential analysis for population PK\/PD data II: robustness of methods","volume":"30","author":"Zhang","year":"2003","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bja.2025.02.038_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ALN.0000000000004115","article-title":"Allometric scaling in pharmacokinetic studies in anesthesiology","volume":"136","author":"Eleveld","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1213\/ANE.0000000000000165","article-title":"A general purpose pharmacokinetic model for propofol","volume":"118","author":"Eleveld","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.02.038_bib24","series-title":"R: a language and environment for statistical computing","year":"2008"},{"key":"10.1016\/j.bja.2025.02.038_bib25","series-title":"Model Selection and Multimodel inference: a practical information-Theoretic approach","author":"Burnham","year":"2002"},{"key":"10.1016\/j.bja.2025.02.038_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2125.2003.01964.x","article-title":"Modelling acute tolerance to the EEG effect of two benzodiazepines","volume":"57","author":"Ihmsen","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2025.02.038_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/ALN.0000000000004811","article-title":"Target-controlled infusion of remimazolam in healthy volunteers shows some acute tolerance","volume":"140","author":"Vellinga","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01143186","article-title":"Measuring the predictive performance of computer-controlled infusion pumps","volume":"20","author":"Varvel","year":"1992","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.bja.2025.02.038_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2044.1988.tb09059.x","article-title":"Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion","volume":"43","author":"Sch\u00fcttler","year":"1988","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2025.02.038_bib30","series-title":"Miller\u2019s Anesthesia","first-page":"439","article-title":"Intravenous drug delivery systems","author":"Glass","year":"2005"},{"key":"10.1016\/j.bja.2025.02.038_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bja.2020.05.051","article-title":"Target-controlled-infusion models for remifentanil dosing consistent with approved recommendations","volume":"125","author":"Eleveld","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.02.038_bib32","unstructured":"BYFAVO drug label Available from: https:\/\/www.accessdata.fda.gov\/spl\/data\/e612bcf4-fce1-4b8b-aa7a-a58ad0dce6b2\/e612bcf4-fce1-4b8b-aa7a-a58ad0dce6b2.xml (accessed 3 May 2024)."},{"key":"10.1016\/j.bja.2025.02.038_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","article-title":"A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy","volume":"88","author":"Rex","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bja.2025.02.038_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","article-title":"Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy","volume":"155","author":"Pastis","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.bja.2025.02.038_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo-and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.02.038_bib36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bja.2018.01.018","article-title":"Pharmacokinetic\u2013pharmacodynamic model for propofol for broad application in anaesthesia and sedation","volume":"120","author":"Eleveld","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.02.038_bib37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/ALN.0000000000001634","article-title":"An allometric model of remifentanil pharmacokinetics and pharmacodynamics","volume":"126","author":"Eleveld","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.02.038_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40262-019-00824-7","article-title":"Evaluating the relationship between lean liver volume and fat-free mass","volume":"59","author":"Sinha","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.02.038_bib39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","article-title":"Quantification of lean bodyweight","volume":"44","author":"Janmahasatian","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.02.038_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40262-015-0277-z","article-title":"Prediction of fat-free mass in children","volume":"54","author":"Al-Sallami","year":"2015","journal-title":"Clin Pharmacokinet"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:14:04Z","timestamp":1774415644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0007091225001928"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.02.038","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}